Global Gastrointestinal Bleeding Treatment Market to Surpass a Value of US$ 849.79 by 2026 end

The global gastrointestinal bleeding treatment market is set to expand moderately at a CAGR of 5.1% between 2020 and 2026, attributed to preference for endoscopic hemostasis to correct GI problems.

Gastrointestinal problems, particularly upper gastrointestinal bleeding (UGIB), are becoming more prevalent across the world. It is, therefore, no surprise to notice an upsurge in the cases of hospitalization across the world. The gastrointestinal bleeding treatment guidelines necessitate the need for surgical intervention which has increased multifold since the past few years.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4760

Since it is known to reduce mortality rates, the method is becoming very common amongst doctors. In addition, new product launches, such as Cook Medical’s Hemospray, is set to offer significant traction to the Gastrintestinal bleeding treatment market in the future.

Key Takeaways of Global Gastrointestinal Bleeding Treatment Market Study

  • Mechanical endoscopic hemostatic devices are expected to gain traction during the forecast period. Techniques such as band ligation, which is suitable for treating esophageal varices, shall drive the growth of this segment. Projected CAGR for mechanical devices is pegged at an impressive 6.1%.
  • The upper GI tract division shall dominate the market share of gastrointestinal bleeding treatment segment. It is expected to account for almost three-fourth of the total market share. This is because upper GI tract bleeding is the most frequent emergency which is reported.
  • By end-use, hospitals are expected to lead the endoscope hemostatic devices markets. This is because hospitals enjoy significant reimbursement benefits along with advanced technology for treatment. The hospitals segment shall account for three-fifth of the GI bleeding treatment market.
  • North America is projected to retain market dominance during the forecast period. Increasing hospitalization rate, strong presence of market leaders and product approvals such as the approval of Hemospray, are leading drivers of the burgeoning market share.

For critical insights on this market, request for methodology here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4760

  • Asia-Pacific is anticipated to register a healthy CAGR of 6% during the forecast period. This is courtesy increasing geriatric population, growing incidence of GI problems and significant product launches and acquisitions.

Gastrointestinal bleeding treatment market segmentation

Fact.MR has studied the gastrointestinal bleeding treatment market with detailed segmentation on the basis of product, GI tract division, end-users and key regions.

Product GI Tract Division End-users Key Regions
  • Endoscopic Hemostatic Devices:
  • Thermal Devices
  • Mechanical Devices
  • Upper GI Tract
  • Hospitals
  • North America
  • Closure Devices
  • Lower GI Tract
  • Clinics
  • Europe
  • Others
 
  • Ambulatory Surgical Centers
  • Asia Pacific
   
  • Others
  • Latin America
     
  • Middle East & Africa

 

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4760

Product Launches to Remain Key Growth Driver for Market Players

The global gastrointestinal bleeding treatment market consists of three major players, contributing half of the total revenue. These companies are Boston Scientific Corporation, Cook Medical and Olympus Corporation. Boston Scientific Corporation manufactures Speedband Superview Super 7TM Multiple Band Ligator.

These devices are used for endoscopic ligation of esophageal varices and anorectal hemorrhoids. Additionally, the company provides Compliance EndoKit, a customized kit designed to prevent the spread of infections during an endoscopy. It provides simple substances such as the CinchPadTM transport pad and SafeStartTM bedside cleaning kits which ensures basic hygiene while performing GI surgeries. Olympus Corporation, another market leader, concentrates on expansion of manufacturing facilities and leveraging healthcare awareness programs to stimulate early diagnosis of diseases. It focuses on reform and development activities related to medical systems across the world.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/04/01/1790807/0/en/Lewy-Body-Dementia-Treatment-Market-Driven-by-Surging-Cholinesterase-Inhibitor-Sales-Fact-MR-Study.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Back to top button